Literature DB >> 20590705

Review of published information on foam sclerotherapy.

Markus Stücker1, Stephan Kobus, Peter Altmeyer, Stefanie Reich-Schupke.   

Abstract

BACKGROUND: New data on foam sclerotherapy of varicose veins has been recently published.
OBJECTIVE: To identify the current treatment modalities and their effectiveness in use of foam sclerotherapy.
MATERIALS AND METHODS: Review of the recent literature regarding clinical treatment of varicose veins using foam sclerotherapy, with emphasis on safety and efficacy. RESULTS Foam sclerotherapy of the great saphenous vein is more effective than liquid. Higher sclerosant concentrations tend to induce higher occlusion. Catheter-assisted sclerotherapy may further improve occlusion rates. To achieve adequate occlusion, vein diameter and volume of foam must be matched. If a critical foam volume is exceeded, the risk of deep venous thrombosis increases. Foam sclerotherapy offers the possibility of using lower sclerosant concentrations than with liquids. Foam sclerotherapy can also be used in venous malformations and periulcerous tributaries. Side effects are hyperpigmentation, skin necrosis, scotoma, and thromboembolic events. Thromboembolism prophylaxis is necessary only in patients with special risk factors.
CONCLUSION: Foam sclerotherapy has significantly better efficacy than liquid. It is essential to select the correct concentration and the correct foam volume. In the hands of an experienced physician, foam sclerotherapy is a safe and effective option for treating varicose veins.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20590705     DOI: 10.1111/j.1524-4725.2009.01406.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  6 in total

1.  Factors that influence perforator thrombosis and predict healing with perforator sclerotherapy for venous ulceration without axial reflux.

Authors:  Misaki M Kiguchi; Eric S Hager; Daniel G Winger; Stanley A Hirsch; Rabih A Chaer; Ellen D Dillavou
Journal:  J Vasc Surg       Date:  2014-01-06       Impact factor: 4.268

2.  [Foam sclerotherapy. Uses and indications in dermatology and phlebology].

Authors:  M Heck; J Faulhaber; F X Breu; S W Schneider
Journal:  Hautarzt       Date:  2012-06       Impact factor: 0.751

3.  Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Authors:  Dario Carugo; Dyan N Ankrett; Xuefeng Zhao; Xunli Zhang; Martyn Hill; Vincent O'Byrne; James Hoad; Mehreen Arif; David D I Wright; Andrew L Lewis
Journal:  Phlebology       Date:  2015-06-01       Impact factor: 1.740

4.  Short Term Outcome of Adjunct Foam Sclerotherapy for Varicose Veins in Patients Subjected to RFA at Dhulikhel Hospital, Nepal.

Authors:  R M Karmacharya; B Shrestha; A Singh; N Chandi; N Bhandari
Journal:  Int J Vasc Med       Date:  2019-10-07

5.  Development of Glycerol-Rose Bengal-Polidocanol (GRP) foam for enhanced sclerosis of a cyst for cystic diseases.

Authors:  Soohyun Jeong; Sujin Kim; Youngjoo Choi; Han Na Jung; Kangwon Lee; Min Hee Park
Journal:  PLoS One       Date:  2021-01-05       Impact factor: 3.240

6.  Polidocanol monotherapy for a superficial orbital venous malformation in a horse.

Authors:  Tara M Stonex; Ashley E Zibura; Michael Andres; Brian C Gilger; Annie Oh
Journal:  Vet Ophthalmol       Date:  2022-06-01       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.